ADVERTISEMENT
This pattern adds weight to the concern, as it suggests the association isn’t simply a coincidence or a reflection of pre-existing health issues.
The research was observational in nature, which means it identifies a statistical association between gabapentin use and cognitive outcomes — not a definitive causal relationship. There are important limitations to acknowledge. The study was unable to analyze specific dosage levels or the exact duration of use for individual participants. Additionally, other factors that weren’t captured in the data could potentially influence the results.
However, the size of the dataset is significant. Analyzing records from tens of thousands of patients across dozens of health systems provides a broad and diverse picture, and the consistency of the findings across different age groups and prescription levels is difficult to dismiss.
Understanding Why Gabapentin Is So Widely Prescribed
Dementia risk rises if you live with chronic pain, study says | CNN
To appreciate the significance of this study, it helps to understand just how prevalent gabapentin use has become in the United States. Originally developed in the early 1990s and approved by the FDA primarily to treat epilepsy, gabapentin has since been embraced by physicians across a wide range of specialties as a go-to option for chronic pain management.
Today, it is one of the most frequently prescribed medications in the country, with tens of millions of prescriptions written annually. Many patients take it continuously over months or even years to manage ongoing pain — exactly the pattern that the new study found to be most closely linked with elevated cognitive risk.
ADVERTISEMENT